Additional Scottish Executive funding of £24m will allow Edinburgh University to develop the £59m centre in collaboration with Scottish Enterprise. The Scottish Centre for Regenerative Medicine (SCRM) is thought to be equalled only one in Kobe, Japan. Prof Ian Wilmut, formerly of the Roslin Institute, will be the director.

The state-of -the-art facilities are expected to house 220 academic researchers and will include a centre for “scale-up” development and manufacture of cells. Space will also be made available for commercial regenerative medicine. It is hoped that the SCRM, which will be part of the new Centre for Biomedical Research at Edinburgh’s Little France, will create about 560 jobs and generate £18.2m per year for the Scottish economy.